奥门丁与血清代谢物概况相关,表明糖尿病风险较低:KORA F4研究
Jacqueline M Ratter-Rieck1,2, Mengya Shi3,4,5, Karsten Suhre6
1Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
BMJ open diabetes research & care
|March 5, 2024
概括
这项研究表明,欧门丁水平与各种代谢物,包括脂质和氨基酸有关,这表明它在全身代谢和胰岛素敏感性中起作用. 需要进一步的研究来了解奥门丁对代谢途径的确切影响.
科学领域:
- 代谢学 代谢学 代谢学
- 内分泌学 在内分泌学.
- 人类生理学 人类生理学
背景情况:
- 循环中的奥门丁水平与胰岛素敏感性正相关.
- 将奥门丁与全身新陈代谢联系在一起的确切机制,特别是与阿迪波涅丁的关系,仍然不清楚.
研究的目的:
- 为了研究血清奥门丁度与广泛的代谢产物之间的关联.
- 阐明奥门丁在全身新陈代谢中的作用及其对胰岛素敏感性和糖尿病风险的潜在影响.
主要方法:
- 从KORA F4研究中分析了1124名参与者 (年龄在61-82岁) 的血清奥门丁度和代谢物概况.
- 利用多变量回归模型,调整了许多混因素,包括代谢,生活方式和临床因素.
主要成果:
- 奥门水平与各种代谢物,包括氨基酸,甲酸和脂质 (如斯芬戈美林和甲酸胆 (PCs)) 显示出显著的关联.
- 特定的类胆 (例如,PC aa C32:1,PC ae C32:2) 和基三甲基卡尼丁 (C14:1-OH) 与奥门丁有显著的关联.
- 在欧门丁度和某些代谢物比率之间观察到负面关联,例如瓦林-PC ae C32: 2 和血清-PC ae C32: 2.
结论:
- 奥门丁可以通过调节全身脂质代谢来影响胰岛素敏感性和糖尿病风险.
- 需要进一步的机制研究来探索奥门丁对胰岛素敏感组织代谢的影响.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
221
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
149
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
01:26Diabetes Mellitus: Introduction
57
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
57
01:26Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
01:24Type II Diabetes II: Pathophysiology
45
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
45
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
32
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32
01:28Diabetic Nephropathy
52
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
52